Page 149 - Case Lab Case Analysis
P. 149

SALES & REVENUE


               For Mylan EpiPen is a complex prescription product,

               implying it’s not something a do-it-yourselfer can make in a

               garage. But, alternatives do exist and it has been shown by

               its latest recall that even large industrial manufacturers can
               get it wrong. Competition is growing and rapidly eroding

               Mylan’s profits.
   144   145   146   147   148   149   150   151   152   153   154